carbamoylmethyl

N6-[N-(6-Aminohexyl)carbamoylmethyl]-CoA (N6-[N-(6-Aminohexyl)carbamoylmethyl]-coenzyme A) is a derivative of coenzyme A.

Repaglinide (AG-EE 623ZW) is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.

1,21-dimethyl (2E,6E,11Z)-19-(carbamoylmethyl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,11-trienedioate is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.

(9E,15E,19E)-3-(carbamoylmethyl)-11,13-dihydroxy-14,21-dimethoxy-8,10,12-trimethyl-7,21-dioxohenicosa-9,15,19-trienoic acid is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.

(2E,6E,12E)-19-(carbamoylmethyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,12-trienedioic acid is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.

2-[(2S,5S)-5-(carbamoylmethyl)-3,6-dioxopiperazin-2-yl]acetamide is a compound used as a molecular structural unit, a cyclic dipeptide. It induces apoptosis, inhibits cell proliferation and modulates immune responses, and possesses a wide range of biological activities including antitumor, antifungal, antibacterial, antiviral and immune-conditioning activities.

3-[3,13,19-tris(carbamoylmethyl)-9-dodecyl-6-(hydroxymethyl)-16-[(4-hydroxyphenyl)methyl]-1,4,7,11,14,17,20,23-octaoxo-hexacosahydro-1H-pyrrolo[2,1-i]1,4,7,10,13,16,19,22-octaazacyclopentacosan-22-yl]propanamide is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.

5-Carbamoylmethyl uridine is a Nucleoside Derivative - 5-Modified pyrimidine nucleoside; Naturally modified Ribo-nucleoside.

'3'-Hydroxy Repaglinide, a primary CYP2C8 metabolite of Repaglinide, is derived from carbamoylmethyl benzoic acid and is used in the treatment of type II diabetes.